Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CCL25 Biologics Sequence Review Report 2026: C-C motif chemokine 25 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CCL25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
ACKR5 Biologics Sequence Review Report 2026: Atypical chemokine receptor 5 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ACKR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TNFSF11 Biologics Sequence Review Report 2026: Tumor necrosis factor ligand superfamily member 11 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFSF11 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ACKR2 Biologics Sequence Review Report 2026: Atypical chemokine receptor 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ACKR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CCL21 Biologics Sequence Review Report 2026: C-C motif chemokine 21 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CCL21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CXCR6 Biologics Sequence Review Report 2026: C-X-C chemokine receptor type 6 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CXCR6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CCL24 Biologics Sequence Review Report 2026: C-C motif chemokine 24 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CCL24 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
GPR25 Biologics Sequence Review Report 2026: C-X-C chemokine receptor GPR25 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
10 min read
Factor X deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Factor X deficiency indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Factor XI deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Factor XI deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Factor VII deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Factor VII deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Factor V deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Factor V deficiency indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.